Lets discuss the "Fast Track" press that was announced last week. When will we know if the drug meets the success criteria? What is the potential market for this drug? What is the competition? Rather than bash each other on short term stock price movements, I want to know if any of you think this stock has a viable product(s) and the potential for those products.
Computer, ISIS pharma wouldn't have covered 35% of the research and development costs in association with OGX-011, if there wasn't decent future potential. As for the the "R&D agreement" the terms were recently changed... I don't believe the changes were made due to a request by ISIS whatsoever. The management of this new entity, "OGXI", would like to absorb the remaining 18.75 million shares being held in escrow. (Actually due to the RS it would be... 1.04 million shares.) The announcement of a partner for OGX-011 would trigger the milestone immediately and all escrowed shares would be awarded to the former shareholders of Oncogenex. There is plenty of potential, but it's tough for shareholders to move past the disaster that was created by Martino over the past year... Possibly Cormack will be able to be successful in this regard?... Bernie
Dont expect a partner until phase two results is reported. It's going to be a while.